Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Brune Akrich"'
Autor:
James A. Karlowsky, Sibylle H. Lob, Fakhar Siddiqui, Brune Akrich, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Stephen P. Hawser, Daniel F. Sahm
Publikováno v:
Journal of Medical Microbiology. 72
Introduction. Piperacillin/tazobactam and carbapenems are important agents for the treatment of serious Gram-negative infections in hospitalized patients. Resistance to both agents is a significant concern in clinical isolates of Enterobacterales and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::931797a0af11a71f41415b955281fb98
https://doi.org/10.1099/jmm.0.001645
https://doi.org/10.1099/jmm.0.001645
Autor:
D. Boutoille, Carole Mackosso, Brune Akrich, Anna Amode, Bernard Castan, Joy Mootien, Raymond Ruimy, Fabrice Ruiz, Anne Berthelot, Lucie Mathis, Jean-François Timsit, Laurie Levy-Bachelot
Publikováno v:
Infectious Diseases Now. 51:532-539
Objectives To describe the real-world clinical use of ceftolozane/tazobactam (C/T) and associated outcomes in France. Patients and methods Multicenter, prospective cohort study conducted in 22 hospitals. All adult patients who received at least one d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710f9d67fc7fe462399bb6fea64093c6
https://doi.org/10.1016/j.idnow.2021.05.003
https://doi.org/10.1016/j.idnow.2021.05.003
Autor:
James A. Karlowsky, Sibylle H. Lob, Fakhar Siddiqui, Brune Akrich, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Stephen P. Hawser, Daniel F. Sahm
Publikováno v:
International Journal of Antimicrobial Agents. 61:106772
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c1cd7f78bface9121031d66dbdf8de8
https://doi.org/10.1016/j.ijantimicag.2023.106772
https://doi.org/10.1016/j.ijantimicag.2023.106772
Autor:
Jacqueline Pavia, Meredith Hackel, Wei-Ting Chen, C Andrew DeRyke, Irina Alekseeva, Brune Akrich, Mary Motyl, Diego Lopez, Brandon Palermo, Pamela A. Moise, Marcela Gonzalez
Publikováno v:
JAC-Antimicrobial Resistance
Objectives To describe the pathogen predominance and to evaluate the probability of covering the most common Gram-negative pathogens collectively in both empirical and early adjustment prescribing scenarios in ICU patients with respiratory infections
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d243b7080e8fb1cf6cf9414b166d9c1a
http://europepmc.org/articles/PMC8209971
http://europepmc.org/articles/PMC8209971
Autor:
Meredith Hackel, Brune Akrich, Daniel F. Sahm, C Andrew DeRyke, Irina Alekseeva, Mary Motyl, Katherine Young, Pamela A. Moise, Diego Lopez, Marcela Gonzalez
Publikováno v:
Open Forum Infectious Diseases
Background Recent data have shown high rates of resistance and co-resistance of P. aeruginosa (PsA) to traditional first-line β-lactam antibiotics (piperacillin/tazobactam, ceftazidime, cefepime, and meropenem), with < 45% susceptibility to the othe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5920a9c843b1ff42988a7301d03c2ba
http://europepmc.org/articles/PMC7778114
http://europepmc.org/articles/PMC7778114